BRAIN Biotech AG

About:

BRAIN Biotech is an enzyme developer and manufacturer. It also develops microbial production strains and bioprocesses.

Website: https://www.brain-biotech-group.com

Twitter/X: BRAINbiotech

Top Investors: MIG Fonds, MP Beteiligungs

Description:

As industrial biotechnology specialists, BRAIN Biotech develops and produces enzymes, proteins, microbial production strains and bioactive natural products for industrial applications. In addition, the company´s innovative biosolutions help make industrial processes more sustainable. The company focuses on food & beverages, life science, and environmental topics. BRAIN Biotech AG is the parent company of the BRAIN Biotech Group and has been listed on the Prime Standard of the Frankfurt Stock Exchange since 9 February 2016 (ticker symbol: BNN).

Total Funding Amount:

65M EUR

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Zwingenberg, Hessen, Germany

Founded Date:

1993-09-01

Contact Email:

public(AT)brain-biotech.de

Founders:

Adriaan Moelker, Dr. Holger Zinke

Number of Employees:

251-500

Last Funding Date:

2024-02-29

IPO Status:

Public

Industries:

© 2025 bioDAO.ai